Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
IOVA
IOVANCE BIOTHERAPEUTICS, INC.
NASDAQ · Biological Products, (No Diagnostic Substances)
Last close
$14.82
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
Market cap
$6.71B
RECENT INSIDER TRADES
2026-09-10
· BILINSKY IGOR
(Chief Operating Officer)
· OTHER
2026-09-10
· Vogt Frederick G
(Interim CEO & General Counsel)
· OTHER
2026-09-10
· Puri Raj K.
(Chief Regulatory Officer)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
319
Shares held
342,484,591
Value
$1.45B
Percent of shares outstanding
75.61%
As of quarter end
2026-06-30
RECENT NEWS
Iovance Biotherapeutics appoints Noah Berkowitz as chief medical officer
Iovance Biotherapeutics raises revenue guidance
Iovance Biotherapeutics raises 2026 revenue guidance to $410-$420 million
Iovance grants 179,750 stock options to 18 new employees
Iovance Biotherapeutics stock reaches 52-week high of $9.36
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit